nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Platelet count decreased—Hydroxyurea—head and neck cancer	0.021	0.021	CcSEcCtD
Meropenem—Application site pain—Fluorouracil—head and neck cancer	0.0205	0.0205	CcSEcCtD
Meropenem—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.0197	0.0197	CcSEcCtD
Meropenem—Ileus—Vinblastine—head and neck cancer	0.0194	0.0194	CcSEcCtD
Meropenem—Skin ulcer—Hydroxyurea—head and neck cancer	0.0161	0.0161	CcSEcCtD
Meropenem—Creatinine increased—Hydroxyurea—head and neck cancer	0.0132	0.0132	CcSEcCtD
Meropenem—Blood urea increased—Hydroxyurea—head and neck cancer	0.0118	0.0118	CcSEcCtD
Meropenem—Phlebitis—Vinblastine—head and neck cancer	0.0116	0.0116	CcSEcCtD
Meropenem—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0111	0.0111	CcSEcCtD
Meropenem—Oral candidiasis—Docetaxel—head and neck cancer	0.0102	0.0102	CcSEcCtD
Meropenem—Hepatic failure—Hydroxyurea—head and neck cancer	0.0101	0.0101	CcSEcCtD
Meropenem—Leukocytosis—Fluorouracil—head and neck cancer	0.00959	0.00959	CcSEcCtD
Meropenem—Intestinal obstruction—Docetaxel—head and neck cancer	0.00954	0.00954	CcSEcCtD
Meropenem—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00945	0.00945	CcSEcCtD
Meropenem—Inflammation—Fluorouracil—head and neck cancer	0.00929	0.00929	CcSEcCtD
Meropenem—Ileus—Docetaxel—head and neck cancer	0.00919	0.00919	CcSEcCtD
Meropenem—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00851	0.00851	CcSEcCtD
Meropenem—Pleural effusion—Docetaxel—head and neck cancer	0.00849	0.00849	CcSEcCtD
Meropenem—Sepsis—Fluorouracil—head and neck cancer	0.00782	0.00782	CcSEcCtD
Meropenem—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00757	0.00757	CcSEcCtD
Meropenem—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00756	0.00756	CcSEcCtD
Meropenem—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00753	0.00753	CcSEcCtD
Meropenem—Myocardial infarction—Vinblastine—head and neck cancer	0.00753	0.00753	CcSEcCtD
Meropenem—Dysuria—Hydroxyurea—head and neck cancer	0.00735	0.00735	CcSEcCtD
Meropenem—Neutropenia—Hydroxyurea—head and neck cancer	0.00735	0.00735	CcSEcCtD
Meropenem—Agranulocytosis—Vinblastine—head and neck cancer	0.00717	0.00717	CcSEcCtD
Meropenem—Infestation—Hydroxyurea—head and neck cancer	0.007	0.007	CcSEcCtD
Meropenem—Infestation NOS—Hydroxyurea—head and neck cancer	0.007	0.007	CcSEcCtD
Meropenem—Haemoglobin—Vinblastine—head and neck cancer	0.00693	0.00693	CcSEcCtD
Meropenem—Haemorrhage—Vinblastine—head and neck cancer	0.00689	0.00689	CcSEcCtD
Meropenem—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00688	0.00688	CcSEcCtD
Meropenem—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00687	0.00687	CcSEcCtD
Meropenem—Pharyngitis—Vinblastine—head and neck cancer	0.00684	0.00684	CcSEcCtD
Meropenem—Inflammation—Docetaxel—head and neck cancer	0.00671	0.00671	CcSEcCtD
Meropenem—Cardiac failure—Fluorouracil—head and neck cancer	0.0067	0.0067	CcSEcCtD
Meropenem—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00662	0.00662	CcSEcCtD
Meropenem—Respiratory failure—Docetaxel—head and neck cancer	0.00662	0.00662	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00654	0.00654	CcSEcCtD
Meropenem—Pulmonary embolism—Docetaxel—head and neck cancer	0.0065	0.0065	CcSEcCtD
Meropenem—Injection site reaction—Docetaxel—head and neck cancer	0.00647	0.00647	CcSEcCtD
Meropenem—Haemoglobin—Hydroxyurea—head and neck cancer	0.00632	0.00632	CcSEcCtD
Meropenem—Haemorrhage—Hydroxyurea—head and neck cancer	0.00629	0.00629	CcSEcCtD
Meropenem—Hallucination—Hydroxyurea—head and neck cancer	0.00626	0.00626	CcSEcCtD
Meropenem—Colitis—Docetaxel—head and neck cancer	0.00625	0.00625	CcSEcCtD
Meropenem—Cardiac arrest—Fluorouracil—head and neck cancer	0.00622	0.00622	CcSEcCtD
Meropenem—Candida infection—Docetaxel—head and neck cancer	0.00621	0.00621	CcSEcCtD
Meropenem—Neuropathy—Docetaxel—head and neck cancer	0.00611	0.00611	CcSEcCtD
Meropenem—Pulmonary oedema—Docetaxel—head and neck cancer	0.00579	0.00579	CcSEcCtD
Meropenem—Sepsis—Docetaxel—head and neck cancer	0.00564	0.00564	CcSEcCtD
Meropenem—Chills—Hydroxyurea—head and neck cancer	0.00564	0.00564	CcSEcCtD
Meropenem—Eosinophilia—Fluorouracil—head and neck cancer	0.0056	0.0056	CcSEcCtD
Meropenem—Anaemia—Vinblastine—head and neck cancer	0.00555	0.00555	CcSEcCtD
Meropenem—Phlebitis—Docetaxel—head and neck cancer	0.00548	0.00548	CcSEcCtD
Meropenem—Erythema—Hydroxyurea—head and neck cancer	0.00547	0.00547	CcSEcCtD
Meropenem—Thrombophlebitis—Docetaxel—head and neck cancer	0.00545	0.00545	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00543	0.00543	CcSEcCtD
Meropenem—Malaise—Vinblastine—head and neck cancer	0.00541	0.00541	CcSEcCtD
Meropenem—Leukopenia—Vinblastine—head and neck cancer	0.00537	0.00537	CcSEcCtD
Meropenem—Hepatic failure—Docetaxel—head and neck cancer	0.00525	0.00525	CcSEcCtD
Meropenem—Hypertension—Vinblastine—head and neck cancer	0.00518	0.00518	CcSEcCtD
Meropenem—Pneumonia—Fluorouracil—head and neck cancer	0.00507	0.00507	CcSEcCtD
Meropenem—Anaemia—Hydroxyurea—head and neck cancer	0.00506	0.00506	CcSEcCtD
Meropenem—Infestation NOS—Fluorouracil—head and neck cancer	0.00504	0.00504	CcSEcCtD
Meropenem—Infestation—Fluorouracil—head and neck cancer	0.00504	0.00504	CcSEcCtD
Meropenem—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00497	0.00497	CcSEcCtD
Meropenem—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00494	0.00494	CcSEcCtD
Meropenem—Myocardial infarction—Fluorouracil—head and neck cancer	0.00494	0.00494	CcSEcCtD
Meropenem—Malaise—Hydroxyurea—head and neck cancer	0.00494	0.00494	CcSEcCtD
Meropenem—Leukopenia—Hydroxyurea—head and neck cancer	0.0049	0.0049	CcSEcCtD
Meropenem—Cardiac failure—Docetaxel—head and neck cancer	0.00484	0.00484	CcSEcCtD
Meropenem—Thrombocytopenia—Vinblastine—head and neck cancer	0.0048	0.0048	CcSEcCtD
Meropenem—Epistaxis—Fluorouracil—head and neck cancer	0.00475	0.00475	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00472	0.00472	CcSEcCtD
Meropenem—Agranulocytosis—Fluorouracil—head and neck cancer	0.0047	0.0047	CcSEcCtD
Meropenem—Anorexia—Vinblastine—head and neck cancer	0.00467	0.00467	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00463	0.00463	CcSEcCtD
Meropenem—Haemoglobin—Fluorouracil—head and neck cancer	0.00455	0.00455	CcSEcCtD
Meropenem—Haemorrhage—Fluorouracil—head and neck cancer	0.00453	0.00453	CcSEcCtD
Meropenem—Pharyngitis—Fluorouracil—head and neck cancer	0.00449	0.00449	CcSEcCtD
Meropenem—Oedema—Hydroxyurea—head and neck cancer	0.00447	0.00447	CcSEcCtD
Meropenem—Infection—Hydroxyurea—head and neck cancer	0.00444	0.00444	CcSEcCtD
Meropenem—Paraesthesia—Vinblastine—head and neck cancer	0.0044	0.0044	CcSEcCtD
Meropenem—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00438	0.00438	CcSEcCtD
Meropenem—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00437	0.00437	CcSEcCtD
Meropenem—Skin disorder—Hydroxyurea—head and neck cancer	0.00434	0.00434	CcSEcCtD
Meropenem—Anorexia—Hydroxyurea—head and neck cancer	0.00426	0.00426	CcSEcCtD
Meropenem—Decreased appetite—Vinblastine—head and neck cancer	0.00426	0.00426	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Meropenem—Constipation—Vinblastine—head and neck cancer	0.00419	0.00419	CcSEcCtD
Meropenem—Pain—Vinblastine—head and neck cancer	0.00419	0.00419	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00416	0.00416	CcSEcCtD
Meropenem—Feeling abnormal—Vinblastine—head and neck cancer	0.00404	0.00404	CcSEcCtD
Meropenem—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00401	0.00401	CcSEcCtD
Meropenem—Dyspnoea—Hydroxyurea—head and neck cancer	0.00398	0.00398	CcSEcCtD
Meropenem—Somnolence—Hydroxyurea—head and neck cancer	0.00397	0.00397	CcSEcCtD
Meropenem—Erythema—Fluorouracil—head and neck cancer	0.00394	0.00394	CcSEcCtD
Meropenem—Dyspepsia—Hydroxyurea—head and neck cancer	0.00393	0.00393	CcSEcCtD
Meropenem—Decreased appetite—Hydroxyurea—head and neck cancer	0.00388	0.00388	CcSEcCtD
Meropenem—Abdominal pain—Vinblastine—head and neck cancer	0.00387	0.00387	CcSEcCtD
Meropenem—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00386	0.00386	CcSEcCtD
Meropenem—Constipation—Hydroxyurea—head and neck cancer	0.00382	0.00382	CcSEcCtD
Meropenem—Pain—Hydroxyurea—head and neck cancer	0.00382	0.00382	CcSEcCtD
Meropenem—Neutropenia—Docetaxel—head and neck cancer	0.00382	0.00382	CcSEcCtD
Meropenem—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00368	0.00368	CcSEcCtD
Meropenem—Pneumonia—Docetaxel—head and neck cancer	0.00366	0.00366	CcSEcCtD
Meropenem—Anaemia—Fluorouracil—head and neck cancer	0.00364	0.00364	CcSEcCtD
Meropenem—Infestation—Docetaxel—head and neck cancer	0.00364	0.00364	CcSEcCtD
Meropenem—Infestation NOS—Docetaxel—head and neck cancer	0.00364	0.00364	CcSEcCtD
Meropenem—Hypersensitivity—Vinblastine—head and neck cancer	0.00361	0.00361	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00361	0.00361	CcSEcCtD
Meropenem—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00359	0.00359	CcSEcCtD
Meropenem—Renal failure—Docetaxel—head and neck cancer	0.00358	0.00358	CcSEcCtD
Meropenem—Myocardial infarction—Docetaxel—head and neck cancer	0.00357	0.00357	CcSEcCtD
Meropenem—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00357	0.00357	CcSEcCtD
Meropenem—Jaundice—Docetaxel—head and neck cancer	0.00355	0.00355	CcSEcCtD
Meropenem—Body temperature increased—Hydroxyurea—head and neck cancer	0.00353	0.00353	CcSEcCtD
Meropenem—Leukopenia—Fluorouracil—head and neck cancer	0.00353	0.00353	CcSEcCtD
Meropenem—Asthenia—Vinblastine—head and neck cancer	0.00351	0.00351	CcSEcCtD
Meropenem—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00344	0.00344	CcSEcCtD
Meropenem—Epistaxis—Docetaxel—head and neck cancer	0.00343	0.00343	CcSEcCtD
Meropenem—Agranulocytosis—Docetaxel—head and neck cancer	0.0034	0.0034	CcSEcCtD
Meropenem—Chest pain—Fluorouracil—head and neck cancer	0.00335	0.00335	CcSEcCtD
Meropenem—Diarrhoea—Vinblastine—head and neck cancer	0.00335	0.00335	CcSEcCtD
Meropenem—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00329	0.00329	CcSEcCtD
Meropenem—Haemoglobin—Docetaxel—head and neck cancer	0.00328	0.00328	CcSEcCtD
Meropenem—Haemorrhage—Docetaxel—head and neck cancer	0.00327	0.00327	CcSEcCtD
Meropenem—Hepatitis—Docetaxel—head and neck cancer	0.00327	0.00327	CcSEcCtD
Meropenem—Confusional state—Fluorouracil—head and neck cancer	0.00324	0.00324	CcSEcCtD
Meropenem—Pharyngitis—Docetaxel—head and neck cancer	0.00324	0.00324	CcSEcCtD
Meropenem—Dizziness—Vinblastine—head and neck cancer	0.00324	0.00324	CcSEcCtD
Meropenem—Oedema peripheral—Docetaxel—head and neck cancer	0.00322	0.00322	CcSEcCtD
Meropenem—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00322	0.00322	CcSEcCtD
Meropenem—Oedema—Fluorouracil—head and neck cancer	0.00322	0.00322	CcSEcCtD
Meropenem—Asthenia—Hydroxyurea—head and neck cancer	0.0032	0.0032	CcSEcCtD
Meropenem—Infection—Fluorouracil—head and neck cancer	0.00319	0.00319	CcSEcCtD
Meropenem—Nervous system disorder—Fluorouracil—head and neck cancer	0.00315	0.00315	CcSEcCtD
Meropenem—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00315	0.00315	CcSEcCtD
Meropenem—Tachycardia—Fluorouracil—head and neck cancer	0.00314	0.00314	CcSEcCtD
Meropenem—Vomiting—Vinblastine—head and neck cancer	0.00311	0.00311	CcSEcCtD
Meropenem—Erythema multiforme—Docetaxel—head and neck cancer	0.00309	0.00309	CcSEcCtD
Meropenem—Headache—Vinblastine—head and neck cancer	0.00307	0.00307	CcSEcCtD
Meropenem—Anorexia—Fluorouracil—head and neck cancer	0.00306	0.00306	CcSEcCtD
Meropenem—Diarrhoea—Hydroxyurea—head and neck cancer	0.00306	0.00306	CcSEcCtD
Meropenem—Hypotension—Fluorouracil—head and neck cancer	0.003	0.003	CcSEcCtD
Meropenem—Dizziness—Hydroxyurea—head and neck cancer	0.00295	0.00295	CcSEcCtD
Meropenem—Immune system disorder—Docetaxel—head and neck cancer	0.00295	0.00295	CcSEcCtD
Meropenem—Chills—Docetaxel—head and neck cancer	0.00293	0.00293	CcSEcCtD
Meropenem—Nausea—Vinblastine—head and neck cancer	0.00291	0.00291	CcSEcCtD
Meropenem—Insomnia—Fluorouracil—head and neck cancer	0.00291	0.00291	CcSEcCtD
Meropenem—Paraesthesia—Fluorouracil—head and neck cancer	0.00289	0.00289	CcSEcCtD
Meropenem—Dyspnoea—Fluorouracil—head and neck cancer	0.00287	0.00287	CcSEcCtD
Meropenem—Somnolence—Fluorouracil—head and neck cancer	0.00286	0.00286	CcSEcCtD
Meropenem—Erythema—Docetaxel—head and neck cancer	0.00284	0.00284	CcSEcCtD
Meropenem—Vomiting—Hydroxyurea—head and neck cancer	0.00284	0.00284	CcSEcCtD
Meropenem—Dyspepsia—Fluorouracil—head and neck cancer	0.00283	0.00283	CcSEcCtD
Meropenem—Rash—Hydroxyurea—head and neck cancer	0.00282	0.00282	CcSEcCtD
Meropenem—Dermatitis—Hydroxyurea—head and neck cancer	0.00281	0.00281	CcSEcCtD
Meropenem—Headache—Hydroxyurea—head and neck cancer	0.0028	0.0028	CcSEcCtD
Meropenem—Decreased appetite—Fluorouracil—head and neck cancer	0.00279	0.00279	CcSEcCtD
Meropenem—Dysgeusia—Docetaxel—head and neck cancer	0.00278	0.00278	CcSEcCtD
Meropenem—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00278	0.00278	CcSEcCtD
Meropenem—Back pain—Docetaxel—head and neck cancer	0.00275	0.00275	CcSEcCtD
Meropenem—Pain—Fluorouracil—head and neck cancer	0.00275	0.00275	CcSEcCtD
Meropenem—Nausea—Hydroxyurea—head and neck cancer	0.00265	0.00265	CcSEcCtD
Meropenem—Feeling abnormal—Fluorouracil—head and neck cancer	0.00265	0.00265	CcSEcCtD
Meropenem—Anaemia—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Meropenem—Urticaria—Fluorouracil—head and neck cancer	0.00255	0.00255	CcSEcCtD
Meropenem—Syncope—Docetaxel—head and neck cancer	0.00255	0.00255	CcSEcCtD
Meropenem—Leukopenia—Docetaxel—head and neck cancer	0.00255	0.00255	CcSEcCtD
Meropenem—Body temperature increased—Fluorouracil—head and neck cancer	0.00254	0.00254	CcSEcCtD
Meropenem—Loss of consciousness—Docetaxel—head and neck cancer	0.0025	0.0025	CcSEcCtD
Meropenem—Cough—Docetaxel—head and neck cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Hypertension—Docetaxel—head and neck cancer	0.00245	0.00245	CcSEcCtD
Meropenem—Chest pain—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.0024	0.0024	CcSEcCtD
Meropenem—Hypersensitivity—Fluorouracil—head and neck cancer	0.00237	0.00237	CcSEcCtD
Meropenem—Confusional state—Docetaxel—head and neck cancer	0.00234	0.00234	CcSEcCtD
Meropenem—Anaphylactic shock—Docetaxel—head and neck cancer	0.00232	0.00232	CcSEcCtD
Meropenem—Oedema—Docetaxel—head and neck cancer	0.00232	0.00232	CcSEcCtD
Meropenem—Infection—Docetaxel—head and neck cancer	0.00231	0.00231	CcSEcCtD
Meropenem—Shock—Docetaxel—head and neck cancer	0.00228	0.00228	CcSEcCtD
Meropenem—Nervous system disorder—Docetaxel—head and neck cancer	0.00228	0.00228	CcSEcCtD
Meropenem—Pruritus—Fluorouracil—head and neck cancer	0.00227	0.00227	CcSEcCtD
Meropenem—Thrombocytopenia—Docetaxel—head and neck cancer	0.00227	0.00227	CcSEcCtD
Meropenem—Tachycardia—Docetaxel—head and neck cancer	0.00226	0.00226	CcSEcCtD
Meropenem—Skin disorder—Docetaxel—head and neck cancer	0.00225	0.00225	CcSEcCtD
Meropenem—Anorexia—Docetaxel—head and neck cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Diarrhoea—Fluorouracil—head and neck cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Hypotension—Docetaxel—head and neck cancer	0.00217	0.00217	CcSEcCtD
Meropenem—Dizziness—Fluorouracil—head and neck cancer	0.00213	0.00213	CcSEcCtD
Meropenem—Insomnia—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—head and neck cancer	0.00208	0.00208	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—head and neck cancer	0.00207	0.00207	CcSEcCtD
Meropenem—Somnolence—Docetaxel—head and neck cancer	0.00206	0.00206	CcSEcCtD
Meropenem—Vomiting—Fluorouracil—head and neck cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—head and neck cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Rash—Fluorouracil—head and neck cancer	0.00203	0.00203	CcSEcCtD
Meropenem—Dermatitis—Fluorouracil—head and neck cancer	0.00203	0.00203	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—head and neck cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Headache—Fluorouracil—head and neck cancer	0.00201	0.00201	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.002	0.002	CcSEcCtD
Meropenem—Pain—Docetaxel—head and neck cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Constipation—Docetaxel—head and neck cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—head and neck cancer	0.00191	0.00191	CcSEcCtD
Meropenem—Nausea—Fluorouracil—head and neck cancer	0.00191	0.00191	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—head and neck cancer	0.0019	0.0019	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—head and neck cancer	0.00171	0.00171	CcSEcCtD
Meropenem—Asthenia—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Pruritus—Docetaxel—head and neck cancer	0.00164	0.00164	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—head and neck cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Dizziness—Docetaxel—head and neck cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Vomiting—Docetaxel—head and neck cancer	0.00148	0.00148	CcSEcCtD
Meropenem—Rash—Docetaxel—head and neck cancer	0.00146	0.00146	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—head and neck cancer	0.00146	0.00146	CcSEcCtD
Meropenem—Headache—Docetaxel—head and neck cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Nausea—Docetaxel—head and neck cancer	0.00138	0.00138	CcSEcCtD
